Latest Diabetes: Type II news
Group-Based Lifestyle Intervention Cuts Progression to T2DM
posted November 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
Drug Combo Offers Long-Term Glycemic Control in T2DM
posted November 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Pb Test Article
Metformin Recalled Due to Contamination With Carcinogen
posted November 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
ASN: Finerenone May Slow Progression in CKD With T2DM
posted October 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis Related Articles
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes Monthly Specialist Briefings
Stay Connected
